| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = -$1,472,597 ) (Continued on the next page) |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01NS119650 | Defining cellular states of quiescence in human brain tumors | 000 | 2 | NIH | 11/16/2022 | -$82,644 |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R35GM133441 | Investigating chromatin mechanisms using viral systems | 002 | 3 | NIH | 11/8/2022 | -$31,925 |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R21NS124191 | Discovery of sensorimotor connectivity mechanisms in a continuous topographic map | 000 | 1 | NIH | 11/15/2022 | -$4,431 |
| | 2023 | 2022 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R21AI169085 | Integrating T cell receptor features with gene expression profiles to define T cell specificity and differentiation | 000 | 1 | NIH | 10/14/2022 | -$1 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | K99DE030194 | Targeting the DNA Damage Response in HPV+ Head and Neck Cancer | 000 | 1 | NIH | 11/10/2022 | -$1,470 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R35GM124593 | Investigating how cellular mechanisms interface to maintain energy balance | 001 | 5 | NIH | 11/7/2022 | -$32,950 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01GM074108 | Genetic Conflict Shapes Centromeres and Heterochromatin | 000 | 16 | NIH | 11/7/2022 | -$15,654 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R35GM141457 | Molecular modeling and machine learning for protein structures and interactions | 000 | 1 | NIH | 11/7/2022 | $0 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R35GM124593 | Investigating how cellular mechanisms interface to maintain energy balance | 000 | 5 | NIH | 11/7/2022 | -$110,880 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01GM064386 | Regulation of Chromosome Segregation | 000 | 20 | NIH | 11/7/2022 | -$28 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R35GM140823 | Mechanisms of transcriptional regulation and transcription factor specificity | 000 | 1 | NIH | 11/7/2022 | -$178,837 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | K99GM138920 | Genome-wide mechanisms and dynamics of ATP-dependent chromatin remodeling complexes | 000 | 1 | NIH | 10/30/2022 | -$15,228 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R21NS118249 | The Brain and Maternal Microchimerism | 000 | 1 | NIH | 11/16/2022 | -$17,224 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | K99GM140251 | Molecular impediments to fate-specifying pioneer factor activity during development | 000 | 1 | NIH | 11/4/2022 | -$9,205 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01GM135362 | Selective mRNA translation in developmental disorders | 000 | 2 | NIH | 11/17/2022 | -$191,168 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R35GM118120 | Molecular analysis of genetic recombination and DNA break repair | 000 | 6 | NIH | 11/7/2022 | -$2,308 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R35GM133441 | Investigating chromatin mechanisms using viral systems | 001 | 3 | NIH | 11/8/2022 | -$507 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R35GM133441 | Investigating chromatin mechanisms using viral systems | 001 | 3 | NIH | 11/8/2022 | -$852 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R35GM133441 | Investigating chromatin mechanisms using viral systems | 000 | 3 | NIH | 11/8/2022 | -$3,443 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R35GM119774 | Real-time tracking of virus evolution for vaccine strain selection and epidemiological investigation | 000 | 6 | NIH | 11/8/2022 | -$21,214 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01CA236558 | Statistical Methods for Prospective Evaluation of Biomarkers | 000 | 11 | NIH | 10/1/2022 | -$27,120 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01NS109425 | Topographic mapping by cranial motor neurons | 000 | 4 | NIH | 11/15/2022 | -$21,509 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R35GM119774 | Real-time tracking of virus evolution for vaccine strain selection and epidemiological investigation | 000 | 6 | NIH | 11/8/2022 | -$203,611 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01GM129512 | Joint Analysis of Microbiome and Other Genomic Data Types | 000 | 4 | NIH | 11/8/2022 | -$1,843 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R25GM129842 | Frontiers in Cancer Research | 001 | 4 | NIH | 11/7/2022 | -$8,488 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R25GM129842 | Frontiers in Cancer Research | 000 | 4 | NIH | 11/7/2022 | -$31,230 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R35GM119835 | Regulation of Protein Synthesis by Synonymous Codon Usage | 000 | 6 | NIH | 11/7/2022 | -$1,208 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01GM117446 | Origin firing at repetitive sequences and genome replication - Admin Supplement | 000 | 6 | NIH | 11/7/2022 | -$79,666 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01GM127857 | Molecular Mechanisms That Control the Quality of Synaptic Vesicle Recycling | 001 | 4 | NIH | 11/8/2022 | $0 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01GM105785 | Statistical Methods for RNA-seq Data Analysis | 000 | 8 | NIH | 11/4/2022 | -$75,376 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01GM127857 | Molecular Mechanisms That Control the Quality of Synaptic Vesicle Recycling | 000 | 4 | NIH | 11/8/2022 | -$11,969 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI068614 | HIV Vaccines Clinical Trials Network Leadership and Operations Center | 001 | 15 | NIH | 11/21/2022 | $7,835,038 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | UH3HL147011 | 1/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis | 000 | 2 | NIH | 11/21/2022 | $0 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R35GM142728 | Regulation of Proteasome Capacity | 000 | 1 | NIH | 11/7/2022 | -$1,662 |
| | 2023 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01GM143186 | Cellular mechanisms of nucleocytoplasmic export through Nuclear Envelope Budding | 000 | 1 | NIH | 11/7/2022 | $0 |
| | 2023 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01GM098583 | Mechanisms of epithelial remodeling during organ development in C. elegans | 000 | 8 | NIH | 11/8/2022 | -$54,576 |
| | 2023 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01GM121487 | High-resolution modeling of protein-RNA interfaces | 000 | 4 | NIH | 11/8/2022 | $0 |
| | 2023 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01GM120318 | Cell Cycle Re-entry from quiescence | 000 | 4 | NIH | 11/8/2022 | -$8,967 |
| | 2023 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI126623 | Cell and Gene Therapy for HIV Cure | 000 | 5 | NIH | 10/14/2022 | $0 |
| | 2023 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI126623 | Cell and Gene Therapy for HIV Cure | 000 | 5 | NIH | 10/14/2022 | $0 |
| | 2023 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI126623 | Cell and Gene Therapy for HIV Cure | 000 | 5 | NIH | 10/14/2022 | $0 |
| | 2023 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | S10OD026919 | Fred Hutch Preclinical 3T MRI | 000 | 1 | NIH | 11/14/2022 | -$16 |
| | 2023 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI126623 | Cell and Gene Therapy for HIV Cure | 000 | 5 | NIH | 10/14/2022 | $0 |
| | 2023 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI126623 | Cell and Gene Therapy for HIV Cure | 000 | 5 | NIH | 10/14/2022 | $0 |
| | 2023 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI126623 | Cell and Gene Therapy for HIV Cure | 000 | 5 | NIH | 10/14/2022 | $0 |
| | 2023 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | UM1AI126623 | Cell and Gene Therapy for HIV Cure | 002 | 5 | NIH | 10/21/2022 | -$208,774 |
| | 2023 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | S10OD028685 | High-Performance Compute Cluster for Comprehensive Cancer and Infectious Diseases Research | 000 | 1 | NIH | 11/14/2022 | -$5,226 |
| | 2023 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01AI121129 | Immunoprotective Properties of Tissue-resident Memory T Cells in Mice and Humans within Mucosal Sites | 003 | 5 | NIH | 11/9/2022 | -$1 |
| | 2023 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109-4433 | KING | USA | R01AI121129 | Immunoprotective Properties of Tissue-resident Memory T Cells in Mice and Humans within Mucosal Sites | 000 | 5 | NIH | 10/21/2022 | -$2,600 |
|
